US Stock MarketDetailed Quotes
CRDF Cardiff Oncology
- 2.460
- +0.010+0.41%
Close Nov 26 16:00 ET
- 2.520
- +0.060+2.44%
Post 20:01 ET
125.79MMarket Cap-2589P/E (TTM)
2.530High2.375Low543.67KVolume2.480Open2.450Pre Close1.33MTurnover1.14%Turnover RatioLossP/E (Static)51.13MShares6.42052wk High2.55P/B117.48MFloat Cap1.21052wk Low--Dividend TTM47.76MShs Float81.480Historical High--Div YieldTTM6.33%Amplitude0.450Historical Low2.449Avg Price1Lot Size
Cardiff Oncology Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 17.02%165K | 50.93%163K | 146.99%205K | 26.42%488K | 21.88%156K | 51.61%141K | 18.68%108K | 12.16%83K | 7.52%386K | -3.76%128K |
| Operating revenue | 17.02%165K | 50.93%163K | 146.99%205K | 26.42%488K | 21.88%156K | 51.61%141K | 18.68%108K | 12.16%83K | 7.52%386K | -3.76%128K |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 16.47%12.77M | 3.18%12.71M | -8.22%11.14M | 13.93%45.9M | 10.17%10.49M | 20.64%10.96M | 16.92%12.32M | 8.85%12.14M | 37.91%40.29M | -1.44%9.52M |
| Selling and administrative expenses | 6.36%3.13M | -25.16%3.22M | 1.52%3.13M | -1.05%13.04M | -11.47%2.73M | -4.48%2.94M | 39.21%4.3M | -21.75%3.08M | 11.34%13.18M | -19.74%3.08M |
| -Selling and marketing expense | -25.37%400K | -21.40%459K | ---- | ---- | ---- | -20.94%536K | -15.61%584K | ---- | ---- | ---- |
| -General and administrative expense | 13.44%2.73M | -25.75%2.76M | 1.52%3.13M | -1.05%13.04M | -13.05%4.44M | 0.17%2.4M | 55.05%3.71M | -21.75%3.08M | 11.34%13.18M | -4.22%5.1M |
| Research and development costs | 20.17%9.64M | 18.37%9.49M | -11.53%8.01M | 21.21%32.86M | 20.51%7.76M | 33.50%8.02M | 7.68%8.02M | 25.58%9.05M | 56.00%27.11M | 10.61%6.44M |
| Operating profit | -16.46%-12.6M | -2.76%-12.55M | 9.28%-10.93M | -13.81%-45.41M | -10.01%-10.33M | -20.32%-10.82M | -16.90%-12.21M | -8.83%-12.05M | -38.28%-39.9M | 1.41%-9.39M |
| Net non-operating interest income expense | -30.62%741K | -23.55%805K | -1.49%926K | 157.37%4.07M | 36.22%1.01M | 133.19%1.07M | 316.21%1.05M | 623.08%940K | 498.86%1.58M | 836.71%740K |
| Non-operating interest income | -30.62%741K | -23.55%805K | -1.49%926K | 157.37%4.07M | 36.22%1.01M | 133.19%1.07M | 316.21%1.05M | 623.08%940K | 498.86%1.58M | 836.71%740K |
| Other net income (expense) | -76.19%5K | -860.00%-38K | 96.40%-4K | 74.41%-98K | 71.11%-13K | 158.33%21K | 101.98%5K | -126.53%-111K | -227.67%-383K | -1,000.00%-45K |
| Other non- operating income (expenses) | -76.19%5K | -860.00%-38K | 96.40%-4K | 74.41%-98K | 71.11%-13K | 158.33%21K | 101.98%5K | -126.53%-111K | -2,653.33%-383K | ---45K |
| Income before tax | -21.83%-11.86M | -5.63%-11.78M | 10.80%-10.01M | -7.07%-41.44M | -7.36%-9.34M | -13.53%-9.73M | -6.77%-11.15M | -2.09%-11.22M | -36.81%-38.7M | 7.89%-8.7M |
| Income tax | ||||||||||
| Net income | -21.83%-11.86M | -5.63%-11.78M | 10.80%-10.01M | -7.07%-41.44M | -7.36%-9.34M | -13.53%-9.73M | -6.77%-11.15M | -2.09%-11.22M | -36.81%-38.7M | 7.89%-8.7M |
| Net income continuous Operations | -21.83%-11.86M | -5.63%-11.78M | 10.80%-10.01M | -7.07%-41.44M | -7.36%-9.34M | -13.53%-9.73M | -6.77%-11.15M | -2.09%-11.22M | -36.81%-38.7M | 7.89%-8.7M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -21.83%-11.86M | -5.63%-11.78M | 10.80%-10.01M | -7.07%-41.44M | -7.36%-9.34M | -13.53%-9.73M | -6.77%-11.15M | -2.09%-11.22M | -36.81%-38.7M | 7.89%-8.7M |
| Preferred stock dividends | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%24K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%24K | 0.00%6K |
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -21.81%-11.86M | -5.63%-11.78M | 10.79%-10.02M | -7.07%-41.47M | -7.35%-9.34M | -13.52%-9.74M | -6.77%-11.16M | -2.09%-11.23M | -36.78%-38.73M | 7.89%-8.7M |
| Basic earnings per share | -13.64%-0.25 | -4.00%-0.26 | 12.00%-0.22 | -4.49%-0.93 | -5.00%-0.21 | -10.00%-0.22 | -4.17%-0.25 | 0.00%-0.25 | -21.92%-0.89 | 13.04%-0.2 |
| Diluted earnings per share | -13.64%-0.25 | -4.00%-0.26 | 12.00%-0.22 | -4.49%-0.93 | -5.00%-0.21 | -10.00%-0.22 | -4.17%-0.25 | 0.00%-0.25 | -21.92%-0.89 | 13.04%-0.2 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data